The role of molecular breast imaging in predicting complete tumor response to treatment and residual tumor extent following neoadjuvant therapy.

about

The role of molecular breast imaging in predicting complete tumor response to treatment and residual tumor extent following neoadjuvant therapy.

Item

http://www.wikidata.org/entity/Q55346981

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

The role of molecular breast i ...... following neoadjuvant therapy.

@en

The role of molecular breast i ...... following neoadjuvant therapy.

@nl

type

Item

label

The role of molecular breast i ...... following neoadjuvant therapy.

@en

The role of molecular breast i ...... following neoadjuvant therapy.

@nl

prefLabel

The role of molecular breast i ...... following neoadjuvant therapy.

@en

The role of molecular breast i ...... following neoadjuvant therapy.

@nl

P1476

The role of molecular breast i ...... following neoadjuvant therapy

@en

P2093

Alessandro Fancellu

http://www.w3.org/2001/XMLSchema#string

Angela Spanu

http://www.w3.org/2001/XMLSchema#string

Giuseppe Madeddu

http://www.w3.org/2001/XMLSchema#string

Ilaria Gelo

http://www.w3.org/2001/XMLSchema#string

Sarah Galassi

http://www.w3.org/2001/XMLSchema#string

Susanna Nuvoli

http://www.w3.org/2001/XMLSchema#string

P2860

Journal club: molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts.

Management of patients with locally advanced breast cancer.

Use of tomographic nuclear medicine procedures, SPECT and pinhole SPECT, with cationic lipophilic radiotracers for the evaluation of axillary lymph node status in breast cancer patients.

The use of molecular breast imaging to assess response in women undergoing neoadjuvant therapy for breast cancer: a pilot study

Proof of concept for low-dose molecular breast imaging with a dual-head CZT gamma camera. Part II. Evaluation in patients.

[99mTc]sestamibi and [99mTc]tetrofosmin in oncology: SPET and fusion imaging in lung cancer, malignant lymphomas and brain tumors.

99mTc labelled cationic lipophilic complexes in malignant and benign tumors: the role of SPET and pinhole-SPET in breast cancer, differentiated thyroid carcinoma and hyperparathyroidism.

Molecular breast imaging: use of a dual-head dedicated gamma camera to detect small breast tumors.

99mTc-sestamibi using a direct conversion molecular breast imaging system to assess tumor response to neoadjuvant chemotherapy in women with locally advanced breast cancer

Meta-analysis confirms achieving pathological complete response after neoadjuvant chemotherapy predicts favourable prognosis for breast cancer patients.

P304

2055-2062

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OR.2018.6299

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pier Andrea Serra

Gaia Rocchitta

P577

2018-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29512735

http://www.w3.org/2001/XMLSchema#string

P932

5928762

http://www.w3.org/2001/XMLSchema#string